ABC Survey - do we Meet the Needs of Patients With Advanced Breast Cancer?

March 27, 2015 updated by: Cancer Trials Ireland

ABC Survey: Are we Meeting the Needs of Patients With Advanced Breast Cancer (ABC) in Ireland? A Nationwide Survey

The study will follow a descriptive design involving a survey. Data collection will involve paper based questionnaires. The questionnaires have been developed in conjunction with breast cancer support groups associated with the Irish Cancer Society and patients.

Study Overview

Status

Completed

Conditions

Detailed Description

The purpose of the study is to identify and categorise the need of Metastatic Breast Cancer (MBC) patients in Ireland with particular focus on; quality of life, symptom burden and access to and value of support available.

The study also aims to evaluate future service developments that will provide support to these patients.

Study Type

Observational

Enrollment (Actual)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Ireland
      • Cork, Ireland
        • Bon Secours Hospital
      • Cork, Ireland
        • Cork University Hospital
      • Cork, Ireland
        • South Infirmary - Victoria University Hospital
      • Donegal, Ireland
        • Letterkenny General Hospital
      • Dublin, Ireland
        • Beaumont Hospital
      • Dublin, Ireland, 8
        • Saint James's Hospital
      • Dublin, Ireland, 4
        • Saint Vincent Universtiy Hospital
      • Dublin, Ireland, 7
        • Mater Misericordiae University Hospital and Mater Private Hospital
      • Galway, Ireland
        • Galway University Hospital
      • Kerry, Ireland
        • Kerry General Hospital
      • Limerick, Ireland
        • Midwestern Regional Hospital
      • Sligo, Ireland
        • Sligo General Hospital
      • Waterford, Ireland
        • Waterford Regional Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

All patients must have metastatic breast cancer

Description

Inclusion Criteria:

  • Signed written informed consent
  • Clinical diagnosis of MBC
  • Female aged 18 years or older
  • Able to complete the questionnaires independently

Exclusion Criteria:

  • Any patient who does not meet the above mentioned inclusion criteria.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Metastatic Breast Cancer

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Needs of MBC patients in Ireland
Time Frame: Following analysis of the questionnaires completed by the patients, estimated 24 months
The needs of MBC patients to be identified and categorised with particular focus on; quality of life, symptom burden and access to and value of available support
Following analysis of the questionnaires completed by the patients, estimated 24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Future service developments
Time Frame: Following analysis of the questionnaires completed by patients, estimated 24 months
Evaluation of future service developments that will provide support to these patients
Following analysis of the questionnaires completed by patients, estimated 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cancer Trials Ireland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2013

Primary Completion (Actual)

March 1, 2015

Study Registration Dates

First Submitted

January 24, 2014

First Submitted That Met QC Criteria

January 29, 2014

First Posted (Estimate)

January 31, 2014

Study Record Updates

Last Update Posted (Estimate)

March 30, 2015

Last Update Submitted That Met QC Criteria

March 27, 2015

Last Verified

March 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ICORG 13-01

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metastatic Breast Cancer

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe